Book section : Chapter
Mechanisms of antiviral activity of iminosugars against dengue virus
- Abstract:
- The antiviral mechanism of action of iminosugars against many enveloped viruses, including dengue virus (DENV), HIV, influenza and hepatitis C virus, is believed to be mediated by inducing misfolding of viral N-linked glycoproteins through inhibition of host endoplasmic reticulum-resident α-glucosidase enzymes. This leads to reduced secretion and/or infectivity of virions and hence lower viral titres, both in vitro and in vivo. Free oligosaccharide analysis from iminosugar-treated cells shows that antiviral activity correlates with production of mono- and tri-glucosylated sugars, indicative of inhibition of ER α-glucosidases. We demonstrate that glucose-mimicking iminosugars inhibit isolated glycoprotein and glycolipid processing enzymes and that this inhibition also occurs in primary cells treated with these drugs. Galactose-mimicking iminosugars that have been tested do not inhibit glycoprotein processing but do inhibit glycolipid processing, and are not antiviral against DENV. By comparison, the antiviral activity of glucose-mimetic iminosugars that inhibit endoplasmic reticulum-resident α-glucosidases, but not glycolipid processing, demonstrates that inhibition of α-glucosidases is responsible for iminosugar antiviral activity against DENV. This monograph will review the investigations of many researchers into the mechanisms of action of iminosugars and the contribution of our current understanding of these mechanisms for optimising clinical delivery of iminosugars. The effects of iminosugars on enzymes other than glucosidases, the induction of ER stress and viral receptors will be also put into context. Data suggest that inhibition of α-glucosidases results in inhibited release of virus and is the primary antiviral mechanism of action of iminosugars against DENV.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 822.4KB, Terms of use)
-
- Publisher copy:
- 10.1007/978-981-10-8727-1_20
Authors
- Publisher:
- Springer
- Host title:
- Dengue and Zika: Control and Antiviral Treatment Strategies
- Pages:
- 277–301
- Chapter number:
- 20
- Series:
- Advances in Experimental Medicine and Biology
- Series number:
- 1062
- Place of publication:
- Singapore
- Publication date:
- 2018-05-30
- Edition:
- 1st
- DOI:
- EISSN:
-
2214-8019
- ISSN:
-
0065-2598
- EISBN:
- 9789811087271
- ISBN-10:
- 9811087261
- ISBN-13:
- 9789811087264
- Language:
-
English
- Keywords:
- Subtype:
-
Chapter
- Pubs id:
-
pubs:854329
- UUID:
-
uuid:8a073490-3c31-45f8-a474-afd68f34da80
- Local pid:
-
pubs:854329
- Source identifiers:
-
854329
- Deposit date:
-
2018-06-07
- ARK identifier:
Terms of use
- Copyright holder:
- Springer Nature
- Copyright date:
- 2018
- Rights statement:
- © 2018 Springer Nature Singapore Pte Ltd.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Springer at: https://doi.org/10.1007/978-981-10-8727-1_20
If you are the owner of this record, you can report an update to it here: Report update to this record